These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 35419377)

  • 1. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digenic Alport Syndrome.
    Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic study of Alport syndrome in Tunisia.
    Younsi ME; Achour A; Kraoua L; Nesrine M; Sayari T; Abderrahim E; Laabidi J; Zouaghi MK; Kharrat M; Gargah T; Trabelsi M; M'rad R
    Pediatr Nephrol; 2025 Jan; 40(1):103-116. PubMed ID: 39138691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Disease Associated With Mono-allelic
    Groen In 't Woud S; Rood IM; Steenbergen E; Willemsen B; Dijkman HB; van Geel M; Schoots J; Wetzels JFM; Lugtenberg D; Deegens JKJ; Bongers EMHF
    Kidney Med; 2023 Apr; 5(4):100607. PubMed ID: 36925663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
    Savige J; Harraka P
    Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome.
    Wang D; Pan M; Li H; Li M; Li P; Xiong F; Xiao H
    BMC Med Genomics; 2024 Jul; 17(1):181. PubMed ID: 38978054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous Pathogenic
    Savige J
    Kidney Int Rep; 2022 Sep; 7(9):1933-1938. PubMed ID: 36090501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.
    Li A; Cui YX; Lv X; Liu JH; Gao EZ; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
    Cytogenet Genome Res; 2018; 154(3):132-136. PubMed ID: 29742505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence Estimates of Predicted Pathogenic
    Gibson J; Fieldhouse R; Chan MMY; Sadeghi-Alavijeh O; Burnett L; Izzi V; Persikov AV; Gale DP; Storey H; Savige J;
    J Am Soc Nephrol; 2021 Sep; 32(9):2273-2290. PubMed ID: 34400539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-Phenotype Correlations for Pathogenic
    Savige J; Huang M; Croos Dabrera MS; Shukla K; Gibson J
    Front Med (Lausanne); 2022; 9():865034. PubMed ID: 35602506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Deeper Insight into
    Yavas C; Ozgenturk NO; Dogan M; Gezdirici A; Keskin E; İli EG; Dogan T; Celebi E; Bender O; Un C
    Mol Syndromol; 2024 Feb; 15(1):1-13. PubMed ID: 38357258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
    Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
    Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Pathological, and Genetic Characteristics of Patients with Digenic Alport Syndrome.
    Inoki Y; Horinouchi T; Yamamura T; Ishimori S; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Kondo A; Sakakibara N; Nagano C; Nozu K
    Kidney360; 2024 Oct; 5(10):1510-1517. PubMed ID: 39137047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Digenic Variants in
    Uedono H; Mori K; Nakatani S; Watanabe K; Nakaya R; Morioka F; Sone K; Ono C; Hotta J; Tsuda A; Morisada N; Seto T; Nozu K; Emoto M
    Case Rep Nephrol Dial; 2024; 14(1):1-9. PubMed ID: 38179179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A founder
    Plevova P; Indrakova J; Savige J; Kuhnova P; Tvrda P; Cerna D; Hilscherova S; Kudrejova M; Polendova D; Jaklova R; Langova M; Jahnova H; Lastuvkova J; Dusek J; Gut J; Vlckova M; Solarova P; Kreckova G; Kantorova E; Soukalova J; Slavkovsky R; Zapletalova J; Tichy T; Thomasova D
    Front Med (Lausanne); 2023; 10():1096869. PubMed ID: 36844206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
    Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.